Table 3.

Unadjusted 1-Year Outcomes Among Patients with Specific Complications

	KM-Estimated Mortality Rate	Mean Change in KCCQ-OS ± SD	Mean Change in SF-12 PCS ± SD	Mean Change in SF-12 MCS ± SD
Patients with no complication	6.8%	26.9 ± 24.11	5.0 ± 10.0	3.8 ± 10.5
Patients with specific complications
Major stroke	49.3%	5.4 ± 25.8	−1.7 ± 8.8	−0.7 ± 18.4
Minor stroke	3.8%	19.0 ± 25.8	3.1 ± 10.4	1.2 ± 9.7
Life-threatening bleed	13.6%	20.0 ± 25.6	2.4 ±10.6	1.6 ± 12.4
Major bleed	14.9%	22.4 ± 25.3	3.5 ± 9.6	2.9 ± 12.9
Major vascular event	11.7%	22.9 ± 24.7	3.2 ± 9.5	2.7 ± 14.3
New pacemaker	13.1%	22.4 ± 23.6	4.9 ± 10.7	3.3 ± 12.3
Acute kidney injury stage 3	51.7%	2.7 ± 30.4	−3.6 ± 16.6	1.5 ± 13.3
Moderate/severe paravalvular leak	17.0%	20.5 ± 23.0	3.2 ± 9.2	1.2 ± 1.6
Mild paravalvular leak	9.6%	22.1 ± 23.7	3.9 ± 10.2	3.5 ± 12.9

KM, Kaplan-Meier; KCCQ-OS, Kansas City Cardiomyopathy Questionnaire-Overall Summary; SF-12, 12-item Medical Outcomes Short Form; PCS, physical component summary; MCS, mental component summary